Beckman Coulter Life Sciences

• Booth: 2037

Even pandemic-related challenges didn’t stop Beckman Coulter Life Sciences from introducing game-changing technology for genomic research. We recently launched the Biomek NGeniuS Next Generation Library Prep System, ideal for labs that want to spend less hands-on time on NGS library preparation. Also new is the time-saving EMnetik 24 System, and related reagents, which bring PCR cleanup and plasmid prep into the 21st century. Both these innovations join our existing portfolio of cleanup reagents and kits for nucleic acid extraction from cells, tissue, blood, cfDNA and FFPE.

Brands: Biomek NGeniuS Next Generation Library Prep System, Biomek i5 Workstation, Echo Liquid Handler, EMnetik 24 System, AMPure XP, SPRI, FormaPure XL, DNAdvance, RNAdvance, GenFind V3, Apostle MiniMax

 Press Releases

• Beckman Coulter Life Sciences Accelerates Next Generation Sequencing by Launching the Biomek NGeniuS Next Generation Library Prep System (Jul 25, 2022)

  Errors, Hands-On-Time Reduced Through Powerful Automation Features

  Indianapolis, IN – (June 28, 2022) Beckman Coulter Life Sciences, a global leader in laboratory workflow automation and innovation, and a company of Danaher Corporation (NYSE: DHR), unleashes the power of next generation sequencing and makes it more accessible for research labs of all sizes with the launch of the Biomek NGeniuS liquid handling system*. The compact instrument automates the labor-intensive process of manual library construction and reagent transfers, helping free up technicians and researchers to focus on the science, not the workflow while also reducing the possibility of errors – all at the touch of a dial.

  The Biomek NGeniuS System virtually eliminates loading errors by combining the optical analytics of Dynamic DeckOptix technology and the user-friendly head-up display to guide users with real-time feedback on guided labware placement. This valuable feature ensures correct deck loading before automatically advancing to the next step. The system also checks for capped reagent vials, incorrect sample input reaction vessels, misplaced or un-removed plate covers, and missing thermal cycling pads.

  “As next generation sequencing becomes a broader focus for labs globally, we uniquely understand the need to deliver an easy solution to help get crucial answers,” said Jason Lanie, Vice President and General Manager of the Biotechnology Business Unit. “With more than 35 years of innovation in liquid handling, we’re uniquely positioned to lead the way for customers looking for automation solutions that provide more time for research instead of addressing workflow bottlenecks. That begins right out of the box, as our user-friendly interface requires no programming skills, offering immediate use and flexibility.”

  The Software Navigation Dial makes it easy for users to simply select the batch and begin to process from four to 24 samples. The Biomek NGeniuS System increases walk-away time with an integrated thermal cycler, labware transport, and reagent aliquoting. A proprietary software portal provides further flexibility, allowing batch setup and system monitoring remotely from a user’s Google Chrome or Microsoft Edge-enabled computer.

  Selective Tip Type ensures the right tip for the right volume without manual intervention, utilizing both 96 and 384 configured tips. Temperature-controlled reagent storage allows users to run end-to-end chemistries and protect reagents from thermal degradation and potential waste of precious samples.

  “The biggest pain point we see with manual library prep is the risk of error and the associated consequences,” said Tony O’Grady, Chief Medical Scientist, Molecular Pathology Laboratory at the Royal College of Surgeons in Ireland at Beaumont Hospital in Dublin. “More important than the financial loss is knowing you’ve potentially wasted a precious sample, which is often only sufficient for one NGS run. The Biomek NGeniuS System helps us ensure we’re getting it right the very first time. The ability to put a DNA sample onto the system, press a button, turn a dial, and walk away is priceless. Staff can focus on the research instead of tedious manual library prep. The NGeniuS System has quite a small footprint for an instrument that's so powerful.”

  Market interest has been strong ahead of the June launch. Several companies, including Integrated DNA Technologies (IDT), Invitae, Illumina, and AmoyDX have signed application development agreements, allowing the development of applications specifically designed for the Biomek NGeniuS liquid handler. These will be available to all users via a first-of-its-kind electronic application plug-and-play library and is designed to evolve with changing lab needs.

  Explore additional Biomek NGeniuS product information.

  *The Biomek NGeniuS Next Generation Library Prep System is not intended or validated for use in the diagnosis of disease or other conditions. In development. Performance characteristics have not been validated.

  Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

  Each app template for use in the Biomek NGeniuS Next Generation Library Prep System has been demonstrated but has not been validated by Beckman Coulter. Beckman Coulter makes no warranties of any kind whatsoever, expressed or implied, with respect to app templates, including, but not limited to, warranties of fitness for a particular purpose or merchantability or that app templates are non-infringing. All warranties are expressly disclaimed. Your use of any app template is solely at your own risk, without recourse to Beckman Coulter.

  Products and demonstrated applications are not intended or validated for use in diagnostic procedures.

  ©2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the Stylized Logo, and Beckman Coulter product and service marks mentioned herein, including Biomek and Biomek NGeniuS, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

• Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System (Jul 25, 2022)

  INDIANAPOLIS – (February 16, 2022) – Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on the Biomek NGeniuS System*.
  
  The Biomek NGeniuS System is a purpose-built liquid handler for next generation sequencing (NGS) library preparation. It provides an easy-to-use automation solution that reduces manual transfers and hands-on time for the traditionally labor-intensive process of NGS library construction. Hands-on time is reduced by innovations which include a reagent input carousel to minimize the manual transfer of reagents, along with an integrated thermal cycler and labware transport system.
  
  “We’re honored that companies continue to turn to Beckman Coulter Life Sciences and put their trust in us,” said Jason Lanie, Vice President and General Manager of the company’s Biotechnology Business Unit. “This is another strong reinforcement of the value we bring to labs and that we’re able to provide a high-performance next generation sequencing solution, further accelerating NGS library prep through purpose-built systems.”
  
  “We are pleased to collaborate with Beckman Coulter Life Sciences, with its deep automation expertise, to expand laboratory access to our NGS-based oncology and genetic disease testing research,” said Joydeep Goswami, Chief Strategy and Corporate Development Officer of Illumina. “Automating in-house testing will reduce turn-around times, improve customer experience, and ultimately enable laboratories to quickly provide relevant, actionable results to healthcare researchers.”
  
  As part of this agreement, Illumina will develop applications specifically designed for the Biomek NGeniuS liquid handler, which will be available to Biomek NGeniuS System users via a first-of-its-kind electronic application library.
  
  The Biomek NGeniuS System is scheduled to launch in the second quarter of 2022. More product information, resources, and previews can be found at https://www.beckman.com/landing/genomics/biomek-ngenius.
  
  
  About Beckman Coulter Life Sciences

  Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Our mission is to empower those seeking answers to life’s important scientific and healthcare questions. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. Genomic reagents. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Wherever people need answers, from prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find Beckman Coulter Life Sciences. For more details, visit beckman.com/contact-us
  
  * IMPORTANT: Beckman Coulter makes no warranties of any kind whatsoever express or implied, with respect to this App Template, including but not limited to warranties of fitness for a particular purpose or merchantability or that the App Template is non-infringing. All warranties are expressly disclaimed. Your use of the App Template is solely at your own risk, without recourse to Beckman Coulter. This App Template has been demonstrated for use on the Biomek NGeniuS system for the chemistry kit version and the release date shown at the time when the App is selected and created, but has not been validated by Beckman Coulter for use in the diagnosis of disease or other clinical conditions.

  Products and demonstrated applications are not intended or validated for use in diagnostic procedures.

  ©2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the Stylized Logo, and Beckman Coulter product and service marks mentioned herein, including Biomek and Biomek NGeniuS, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners

• Beckman Coulter Life Sciences and IDT Enter Into Application Development Agreement For The Biomek NGenius System (Jul 25, 2022)

  INDIANAPOLIS — (November 22, 2021) — Chemistry companies continue seeking partnerships with Beckman Coulter Life Sciences ahead of the 2022 launch of the Biomek NGeniuS Next Generation Library Preparation System. Today, Beckman Coulter Life Sciences announced a second application development agreement for the instrument.

  This latest partnership enables global genomics solutions provider Integrated DNA Technologies (IDT), a supplier of custom nucleic acids and other genomics reagents, to develop new applications on the Biomek NGeniuS System*.

  The Biomek NGeniuS System is a purpose-built liquid handler for next generation sequencing (NGS) library preparation. It provides an easy-to-use automation solution that reduces manual transfers and hands-on time for the traditionally labor-intensive process of NGS library construction.

  “This partnership is the second in a long line of agreements with reagent manufacturers that will allow Beckman Coulter Life Sciences to accelerate the development of applications on our newest NGS library prep instrument, the Biomek NGeniuS liquid handler,” said Jason Lanie, Vice President and General Manager of Beckman Coulter’s Biotechnology Business Unit. “This shows our continued commitment to application development and the speed at which we can provide new NGS applications to our customers. It also combines the expertise of the instrument and reagent manufacturers to produce a higher quality automated NGS library prep solution.”

  Mirna Jarosz, General Manager of NGS at Integrated DNA Technologies, added: “Automating our NGS solutions on Beckman Coulter Life Sciences’ new Biomek NGeniuS System is an important step in making high-performance NGS solutions more accessible to a broader array of labs. IDT remains steadfast in its mission to advance the field of genomics and this partnership exemplifies how two companies are uniting to move science forward.” 

  As part of this agreement, IDT will develop applications specifically designed for the Biomek NGeniuS liquid handler, which will be available to Biomek NGeniuS System users via a first-of-its-kind electronic application library. The Biomek NGeniuS System is scheduled to launch in the first quarter of 2022 

   

  About IDT

  Integrated DNA Technologies, Inc. (IDT) develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP services, IDT manufactures products used by scientists researching many forms of cancer, and most inherited and infectious diseases. IDT is widely recognized as the industry leader in custom nucleic acid manufacture, serving over 130,000 life sciences researchers. IDT was founded in 1987 and has its manufacturing headquarters in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Research Triangle Park, North Carolina, USA; Ann Arbor, Michigan, USA; Leuven, Belgium; and Singapore. For more information, please visit www.idtdna.com and follow IDT on Twitter, LinkedIn, Facebook, YouTube, and Instagram.

   

  About Beckman Coulter Life Sciences

  Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Our mission is to empower those seeking answers to life’s important scientific and healthcare questions. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. Genomic reagents. All of these products — and many more — continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts, and others. Wherever people need answers, from prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage, and electronics manufacturing facilities, you can find Beckman Coulter Life Sciences. For more details, visit beckman.com/contact-us.

   

  * Not intended or validated for use in diagnosis of disease or other conditions.

   

  Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein, including Biomek and Biomek NGeniuS, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

  Disclosure: This product is in development; performance characteristics have not been validated.